default author photo

Martin Faehling

Klinikum Esslingen

Germany

  • Klinikum Esslingen

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

First-Line Nivolumab Plus Ipilimumab in Pleural Mesothelioma: Efficacy and Safety Data from the Real-World MesoNet Study

Number of pages: 14 Posted: 02 Jun 2025
Rajiv Shah, Eva L. Buchmeier, Hans-Georg Kopp, Daniel C. Christoph, Frank Griesinger, Martin Reck, Petra Hoffknecht, Jonas Kuon, Nikolaj Frost, Christian Grohe, Martin Faehling, Jingting Luan, Julia Roeper, Paolo Chesi, Miriam Blasi, Martin Kimmich, Till Olchers, Helge Bischoff, Laura Klotz, Inn Chung, Petros Christopoulos and Michael Thomas
affiliation not provided to SSRN, University of Witten/Herdecke - Kliniken der Stadt Köln gGmbH, Robert Bosch Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, German Centre for Lung Research - Lungen Clinic Grosshansdorf, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Klinikum Esslingen, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Robert Bosch Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Heidelberg University, affiliation not provided to SSRN, Heidelberg University and Heidelberg University
Downloads 36 (1,236,159)

Abstract:

Loading...

mesothelioma, Immunotherapy, First-line, retrospective cohort, epithelioid